JP Stock MarketDetailed Quotes
4503 Astellas Pharma
- 1781.5
- 0.00.00%
20min DelayMarket to Open Nov 1 15:00 JST
3.22TMarket Cap188.12P/E (Static)
0.0High0.0Low0Volume0.0Open1781.5Pre Close0.00Turnover1839.552wk High0.00%Turnover Ratio1.81BShares1426.052wk Low32.78EPS TTM3.08TFloat Cap2360.5Historical High188.12P/E (Static)1.73BShs Float540.0Historical Low9.47EPS LYR0.00%Amplitude72.00Dividend TTM2.00P/B100Lot Size4.04%Div YieldTTM
Astellas Pharma Key Stats
EPS
According to the latest financial report of Astellas Pharma, the latest earnings per share (TTM) for the company is 20.94. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Astellas Pharma's free cash flow? The latest report shows it as -26.75B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Astellas Pharma shows that the company's current ratio is 0.93, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Astellas Pharma, the quick ratio is 0.70, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Astellas Pharma? The latest ROE figure is -2.15%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Astellas Pharma, the total asset return on investment (ROA) is -0.96%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Astellas Pharma's latest financial report to see how their gross margin is doing - currently at 80.74%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Astellas Pharma, the net profit margin is 7.95%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data